Moderna (MRNA) downgraded to Hold from Buy at Jefferies; target lowered to $65 from $120
Moderna (MRNA) downgraded to Underweight from Neutral at JP Morgan; target lowered to $70 from $88
Moderna (MRNA) downgraded to Perform from Outperform at Oppenheimer
AstraZeneca (AZN) downgraded to Sell from Hold at Deutsche Bank